Inmode Ltd. current report, Q2 FY2022

Business Context and Reporting Period

InMode Ltd. furnished this Form 6-K for April 2022, dated April 6, 2022. The filing reports the results of the company’s April 4, 2022 Annual General Meeting of Shareholders.

Financial Metrics and Liquidity

This filing contains no revenue, profit, cash flow, margin, debt, liquidity, or other operating or financial performance information. The filing text does not provide clear values for these metrics.

Meeting Results and Material Changes

  • As of the February 25, 2022 record date, 83,081,080 ordinary shares were issued and outstanding.
  • 45,324,168 shares were present in person or by proxy, representing approximately 54.55% of outstanding shares. A quorum was present.
  • Approved: Re-election of Moshe Mizrahy and Dr. Michael Kreindel as Class III directors, serving until the 2025 annual meeting or earlier departure.
  • Approved: Reappointment of Kesselman & Kesselman, a member of PwC, as independent auditors for the fiscal year ending December 31, 2022 and through the 2023 annual meeting.
  • Approved: Grants of 2,000 restricted share units to each of Dr. Michael Anghel, Bruce Mann, and Dr. Hadar Ron, totaling 6,000 RSUs. Half vest on December 31, 2022 and half on December 31, 2023, subject to continued service.
  • Not approved: Increasing authorized share capital from NIS 1,000,000, comprising 100,000,000 ordinary shares, to NIS 5,000,000, comprising 500,000,000 ordinary shares, and amending the articles accordingly.

Guidance, Outlook, Risks, and Unusual Items

The filing provides no financial guidance or business outlook. The principal unusual item is the failure of the proposal to increase authorized share capital. The RSU awards create future equity-based compensation and dilution potential, subject to vesting and continued service.

Investor Verification Items

  • Verify the detailed vote counts and voting thresholds in the company’s proxy materials and applicable Israeli corporate law.
  • Assess the implications of the rejected increase in authorized share capital for future equity issuance, acquisitions, financing, or other corporate actions.
  • Review the company’s subsequent filings for the accounting impact and dilution associated with the 6,000 RSU awards.
  • Consult the company’s annual report and other filings for financial performance, liquidity, debt, and operating outlook, which are not addressed in this Form 6-K.